Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Quinpirole | 8 | 2025 | 18 | 3.810 |
Why?
|
| Cocaine | 9 | 2024 | 251 | 2.660 |
Why?
|
| Morphine | 3 | 2025 | 69 | 2.570 |
Why?
|
| Dopamine Agonists | 7 | 2025 | 34 | 2.430 |
Why?
|
| Rats, Sprague-Dawley | 20 | 2025 | 1766 | 2.320 |
Why?
|
| Fish Oils | 4 | 2021 | 13 | 2.310 |
Why?
|
| Benzazepines | 4 | 2025 | 33 | 1.810 |
Why?
|
| Rats | 24 | 2025 | 3735 | 1.720 |
Why?
|
| Analgesics, Opioid | 3 | 2025 | 252 | 1.700 |
Why?
|
| Yawning | 7 | 2021 | 7 | 1.650 |
Why?
|
| Behavior, Animal | 6 | 2019 | 373 | 1.500 |
Why?
|
| Eating | 6 | 2025 | 167 | 1.470 |
Why?
|
| Receptors, Dopamine D2 | 5 | 2025 | 83 | 1.400 |
Why?
|
| Avoidance Learning | 6 | 2013 | 70 | 1.370 |
Why?
|
| Methamphetamine | 2 | 2025 | 166 | 1.350 |
Why?
|
| Receptors, Dopamine D3 | 4 | 2025 | 17 | 1.330 |
Why?
|
| Taste | 6 | 2013 | 45 | 1.170 |
Why?
|
| Dietary Carbohydrates | 2 | 2025 | 34 | 1.120 |
Why?
|
| Animals | 27 | 2025 | 16992 | 1.000 |
Why?
|
| Saccharin | 2 | 2015 | 9 | 0.920 |
Why?
|
| Constipation | 1 | 2025 | 7 | 0.920 |
Why?
|
| Drug Tolerance | 1 | 2025 | 26 | 0.920 |
Why?
|
| Dietary Fats | 4 | 2025 | 117 | 0.880 |
Why?
|
| Dose-Response Relationship, Drug | 9 | 2025 | 1124 | 0.880 |
Why?
|
| Locomotion | 4 | 2021 | 105 | 0.880 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2025 | 126 | 0.820 |
Why?
|
| Conditioning, Classical | 2 | 2012 | 67 | 0.700 |
Why?
|
| Male | 22 | 2025 | 23409 | 0.690 |
Why?
|
| Binge-Eating Disorder | 1 | 2021 | 8 | 0.690 |
Why?
|
| Pyridines | 2 | 2025 | 139 | 0.650 |
Why?
|
| Drinking | 3 | 2015 | 37 | 0.640 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2020 | 46 | 0.620 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2020 | 40 | 0.620 |
Why?
|
| Dopamine Uptake Inhibitors | 3 | 2021 | 83 | 0.620 |
Why?
|
| Conditioning, Operant | 5 | 2016 | 90 | 0.610 |
Why?
|
| Insulin Resistance | 5 | 2021 | 201 | 0.580 |
Why?
|
| Piperazines | 2 | 2025 | 120 | 0.570 |
Why?
|
| Obesity | 3 | 2021 | 1151 | 0.540 |
Why?
|
| Dopamine Agents | 2 | 2019 | 28 | 0.510 |
Why?
|
| Dietary Supplements | 4 | 2021 | 213 | 0.510 |
Why?
|
| Corpus Striatum | 1 | 2017 | 121 | 0.500 |
Why?
|
| Brain | 2 | 2021 | 1472 | 0.470 |
Why?
|
| Anti-Obesity Agents | 1 | 2015 | 11 | 0.470 |
Why?
|
| Dietary Sucrose | 1 | 2015 | 17 | 0.470 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 299 | 0.460 |
Why?
|
| Body Weight | 5 | 2019 | 429 | 0.460 |
Why?
|
| Sucrose | 1 | 2015 | 33 | 0.450 |
Why?
|
| Benzamides | 1 | 2015 | 81 | 0.440 |
Why?
|
| Stress, Psychological | 1 | 2021 | 661 | 0.430 |
Why?
|
| Female | 13 | 2025 | 24698 | 0.420 |
Why?
|
| Substance-Related Disorders | 2 | 2024 | 830 | 0.420 |
Why?
|
| Haloperidol | 1 | 2011 | 36 | 0.360 |
Why?
|
| Drug Interactions | 3 | 2020 | 150 | 0.350 |
Why?
|
| 8-Hydroxy-2-(di-n-propylamino)tetralin | 2 | 2025 | 7 | 0.350 |
Why?
|
| Feeding Behavior | 2 | 2019 | 469 | 0.340 |
Why?
|
| Dopamine | 1 | 2012 | 275 | 0.320 |
Why?
|
| Norepinephrine | 1 | 2008 | 97 | 0.290 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2021 | 131 | 0.290 |
Why?
|
| Indoles | 3 | 2015 | 187 | 0.280 |
Why?
|
| Signal Transduction | 1 | 2017 | 2157 | 0.280 |
Why?
|
| Nicotine | 2 | 2021 | 302 | 0.260 |
Why?
|
| Self Administration | 2 | 2024 | 69 | 0.250 |
Why?
|
| Naltrexone | 2 | 2025 | 34 | 0.240 |
Why?
|
| Serotonin Antagonists | 2 | 2016 | 22 | 0.240 |
Why?
|
| Aminopyridines | 1 | 2025 | 26 | 0.230 |
Why?
|
| Head Movements | 2 | 2015 | 5 | 0.220 |
Why?
|
| Benzodioxoles | 1 | 2024 | 4 | 0.220 |
Why?
|
| Insulin | 2 | 2019 | 258 | 0.220 |
Why?
|
| Piperidines | 2 | 2015 | 83 | 0.220 |
Why?
|
| Pyrrolidines | 1 | 2024 | 31 | 0.210 |
Why?
|
| Body Temperature | 2 | 2014 | 35 | 0.210 |
Why?
|
| Risk Factors | 2 | 2021 | 3994 | 0.190 |
Why?
|
| Phenotype | 1 | 2024 | 780 | 0.180 |
Why?
|
| Southeastern United States | 1 | 2021 | 64 | 0.170 |
Why?
|
| Mood Disorders | 1 | 2021 | 54 | 0.160 |
Why?
|
| Blinking | 1 | 2020 | 14 | 0.160 |
Why?
|
| Reward | 1 | 2021 | 112 | 0.160 |
Why?
|
| Penile Erection | 1 | 2019 | 26 | 0.150 |
Why?
|
| Young Adult | 2 | 2021 | 5080 | 0.150 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2019 | 15 | 0.150 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2019 | 28 | 0.150 |
Why?
|
| Fatty Acids | 1 | 2020 | 134 | 0.150 |
Why?
|
| Adolescent | 2 | 2021 | 6081 | 0.150 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2019 | 23 | 0.150 |
Why?
|
| Ventral Tegmental Area | 1 | 2019 | 49 | 0.140 |
Why?
|
| Sex Factors | 2 | 2021 | 1028 | 0.140 |
Why?
|
| Nicotinic Agonists | 1 | 2019 | 88 | 0.140 |
Why?
|
| Nucleus Accumbens | 1 | 2019 | 100 | 0.140 |
Why?
|
| Fear | 1 | 2021 | 272 | 0.140 |
Why?
|
| Leptin | 1 | 2019 | 118 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 734 | 0.130 |
Why?
|
| Reinforcement Schedule | 1 | 2016 | 15 | 0.130 |
Why?
|
| Hypothermia | 2 | 2014 | 13 | 0.130 |
Why?
|
| Blood Glucose | 2 | 2021 | 389 | 0.130 |
Why?
|
| Amphetamines | 1 | 2015 | 5 | 0.120 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 1 | 2015 | 5 | 0.120 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 1 | 2015 | 15 | 0.120 |
Why?
|
| Hypothalamus | 1 | 2016 | 120 | 0.120 |
Why?
|
| Receptor, Serotonin, 5-HT1A | 1 | 2015 | 17 | 0.120 |
Why?
|
| Drug Synergism | 1 | 2016 | 195 | 0.120 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 153 | 0.110 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 140 | 0.110 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 1070 | 0.110 |
Why?
|
| Phosphorylation | 1 | 2017 | 986 | 0.110 |
Why?
|
| Administration, Oral | 1 | 2015 | 260 | 0.110 |
Why?
|
| Energy Intake | 1 | 2015 | 164 | 0.110 |
Why?
|
| Diet | 1 | 2020 | 826 | 0.100 |
Why?
|
| Receptors, Serotonin, 5-HT3 | 1 | 2013 | 7 | 0.100 |
Why?
|
| Humans | 3 | 2021 | 43102 | 0.090 |
Why?
|
| Association Learning | 1 | 2011 | 35 | 0.090 |
Why?
|
| Motor Activity | 1 | 2014 | 437 | 0.090 |
Why?
|
| Child | 1 | 2020 | 3443 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2011 | 575 | 0.080 |
Why?
|
| Rats, Wistar | 2 | 2021 | 283 | 0.080 |
Why?
|
| Time Factors | 1 | 2014 | 1857 | 0.070 |
Why?
|
| Desipramine | 1 | 2008 | 13 | 0.070 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2008 | 15 | 0.070 |
Why?
|
| Aging | 1 | 2014 | 783 | 0.070 |
Why?
|
| Central Nervous System Depressants | 1 | 2008 | 42 | 0.070 |
Why?
|
| Ethanol | 1 | 2008 | 224 | 0.060 |
Why?
|
| Motivation | 1 | 2008 | 513 | 0.050 |
Why?
|
| Cocaine-Related Disorders | 1 | 2024 | 102 | 0.050 |
Why?
|
| Adult | 1 | 2020 | 13872 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2024 | 258 | 0.050 |
Why?
|
| Mecamylamine | 1 | 2021 | 21 | 0.040 |
Why?
|
| Streptozocin | 1 | 2021 | 26 | 0.040 |
Why?
|
| Drinking Behavior | 1 | 2019 | 18 | 0.040 |
Why?
|
| Water | 1 | 2019 | 316 | 0.030 |
Why?
|
| Dynorphins | 1 | 2008 | 17 | 0.020 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2008 | 23 | 0.020 |
Why?
|
| Maternal Behavior | 1 | 2008 | 29 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 125 | 0.020 |
Why?
|
| Extinction, Psychological | 1 | 2008 | 104 | 0.020 |
Why?
|